Singular Genomics Systems Inc
Save
54.53M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Medical - Instruments & Supplies
Industry

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution.

Similar securities

Based on sector and market capitalization

Report issue